Pfizer couldn't bag AstraZeneca and Valeant is still trying win over Allergan's (NYSE: AGN ) shareholders, but AbbVie (NYSE: ABBV ) has managed to close its major deal. AbbVie and Shire
(SHPG) announced on Friday that the companies had agreed to a merger
that will see AbbVie acquire the Irish-based drugmaker on the previously
announced terms of GBP 24.44 cash and 0.896 shares of AbbVie for each
Shire share.
Read the full article here:
AbbVie Inc. Wins the Shire
No comments:
Post a Comment